F-group (family)
304.6.1.3 BBE
Ligands and drugs
404
Member domains
164
with ligand contacts (≤ 4 Å)
40.6% of members
147
with DrugDomain annotations
36.4% of members
145
with a DrugBank compound
35.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 304.6.1.3 belongs to X-group 304 Alpha-beta plaits, which binds 8.8 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 144 |
| DB00141 | NAG | N-Acetylglucosamine | 42 |
| DB09140 | OXY | Oxygen | 4 |
| DB00160 | ALA | Alanine | 2 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 2 |
| DB03389 | XYS | alpha-D-Xylopyranose | 1 |
| DB04096 | ABL | (2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-oxo-3-piperidinyl beta-D-glucopyranoside | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 161 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 45 |
| CL | CHLORIDE ION | 15 |
| NAmetal | SODIUM ION | 12 |
| TIR | TIRANDAMYCIN E | 6 |
| MGmetal | MAGNESIUM ION | 5 |
| OXY | OXYGEN MOLECULE | 4 |
| VGP | (1R)-1,4-anhydro-6-deoxy-1-[(6R)-8-ethenyl-1,6-dihydroxy-10,12-dimethoxy-6H-dibenzo[c,h]chromen-4-yl]-D-galactitol | 4 |
| ZNmetal | ZINC ION | 4 |
| 67L | 6-(hydroxymethyl)[2,2'-bipyridin]-4-ol | 3 |
| FDA | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | 3 |
| MAN | alpha-D-mannopyranose | 3 |
| N1L | 2-amino-2-deoxy-beta-D-glucopyranuronic acid | 3 |
| REN | (S)-reticuline | 3 |
| T55 | 8-METHYLNONANOIC ACID | 3 |
| A1ITD | (2~{Z})-1-[3,5-dimethyl-2,4-bis(oxidanyl)phenyl]hexa-2,4-dien-1-one | 2 |
| A1JEE | (2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-[3-[(2~{S})-1-methylpyrrolidin-2-yl]pyridin-1-yl]oxane-3,4,5-triol | 2 |
| ABL | (2R,3R,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-oxopiperidin-3-yl beta-D-glucopyranoside | 2 |
| FTK | 6,6,6-trifluoro-1-phenylhexane-1,3,5-trione | 2 |
| HTK | (7S)-7-hydroxy-1-phenyloctane-1,3,5-trione | 2 |